Rare Structural Variants Uncovered by Optical Genome Mapping in Multisystem Inflammatory Syndrome in Children (MIS-C)

Catherine A Brownstein1,2, Caspar I van der Made3, Kristin Cabral1

  • 1Division of Genetics and Genomics The Manton Center For Orphan Disease Research Harvard Medical School Boston Children's Hospital Boston Massachusetts USA.

PubMed

Insights

Optical Genome Mapping identified rare structural variants in children with Multisystem Inflammatory Syndrome (MIS-C). These genetic findings may explain disease variations and susceptibility to severe COVID-19 or Kawasaki Disease.

Area of Science:

  • Genetics
  • Pediatrics
  • Immunology

Background:

  • Multisystem Inflammatory Syndrome in Children (MIS-C) is a serious pediatric condition linked to SARS-CoV-2 infection.
  • MIS-C often involves multiorgan inflammation and cardiovascular issues.
  • Understanding the genetic underpinnings of MIS-C is crucial for explaining disease heterogeneity.

Purpose of the Study:

  • To investigate the utility of Optical Genome Mapping (OGM) in identifying structural variants in patients with MIS-C.
  • To explore potential genetic factors contributing to MIS-C, MIS-C-like presentations, and severe COVID-19 outcomes.

Main Methods:

  • A prospective cohort study involving 14 pediatric patients (11 with MIS-C, 3 with MIS-C-like presentations).
  • Optical Genome Mapping (OGM) was performed on all patients.
  • Structural Variants (SVs) and Copy Number Variations (CNVs) were identified and filtered against control databases.

Main Results:

  • Seven out of 14 patients (50%) had prioritized variants near genes involved in immune regulation or SARS-CoV-2 response.
  • Identified variants included insertions/deletions in ORAI1, STAT4, ITPR1, BATF, CFHR5, and DOCK2.
  • OGM revealed SVs potentially influencing inflammation, COVID-19 severity, and Kawasaki Disease susceptibility.

Conclusions:

  • OGM is a feasible and valuable tool for assessing complex pediatric syndromes like MIS-C.
  • Rare structural variants may contribute to the diverse clinical presentations and severity of MIS-C.
  • These findings offer biologically plausible mechanisms for MIS-C heterogeneity and susceptibility.